HomeNewsNeuroscience

  • Scientists discover genesis of Alzheimer’s, call it a “Big Bang” for the disease

    • July 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • MANF Therapeutics announces positive data in Parkinson’s model

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ANAVEX®2-73 approved to initiate trial for Alzheimer’s & Parkinson’s Disease

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ICER report gives thumbs up to Aimovig for Chronic Migraine patients

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Biomarkers identified for Progressive Multiple Sclerosis

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Eisai and Biogen report positive results for Alzheimer’s drug BAN2401

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Titan postpones Parkinson’s implant trial program

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Neupro approved in China to treat Parkinson’s disease

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Pre-clinical data for EHP-101 in Multiple Sclerosis, presented by Emerald

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Ph 3 Efficacy data presented for Eptinezumab in Episodic and Chronic Migraine

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more